We describe a 74-year-old female who presented with thrombocytopenia 20
days after receiving her first dose of the novel mRNA vaccine. After an
exhaustive workup, Immune Thrombocytopenia was diagnosed secondary to
her recent mRNA vaccine administration. She was treated aggressively
with high-dose steroids and IVIG, with adequate response.